Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2005;91:1164-1166; doi:10.1136/hrt.2004.035295
Copyright © 2005 BMJ Publishing Group Ltd & British Cardiovascular Society

CARDIOVASCULAR MEDICINE

Headache response to glyceryl trinitrate in patients with and without obstructive coronary artery disease

D H Hsi1, A Roshandel2, N Singh1, T Szombathy3, Z S Meszaros4

1 Department of Medicine and Cardiology Division, Park Ridge Hospital, Unity Health System, Rochester, New York, USA
2 Department of Cardiology, Providence Hospital, Southfield, Michigan, USA
3 Department of Cardiology, Caritas St Elizabeth’s Medical Center, Boston, Massachusetts, USA
4 Department of Psychiatry, Caritas St Elizabeth’s Medical Center, Boston, Massachusetts, USA

Correspondence to:
Correspondence to:
Dr David H Hsi
1561 Long Pond Road, Suite 401, Rochester, New York 14450, USA; dhsi{at}unityhealth.org

Objectives: To examine the hypothesis that glyceryl trinitrate (GTN) may cause headache in patients with normal coronary arteries more often than in patients with obstructive coronary artery disease (CAD). This simple assessment may aid clinicians in the initial evaluation of chest pain syndrome and possible CAD.

Patients and methods: 118 patients (66 men and 52 women) with new onset of chest pain were enrolled in this study. Patients were excluded from the study if they had a history of chronic headache, long term nitrates use, or any coronary artery procedures. Mean age of the patients was 62.5 years. Coronary angiography was performed within one month of GTN administration with the usual clinical indications such as recurrent chest pain, abnormal ECG, or abnormal results of stress tests. Thirty patients had normal coronary arteries or minimal or non-obstructive CAD. Eighty eight patients had obstructive CAD defined as luminal narrowing greater than 50% in any one or more of the left or right coronary arteries or their major branches. All the patients had a varying degree of relief of chest pain with GTN administration within 10 minutes. 36% of patients reported significant headache after GTN administration.

Results: In patients with normal coronary arteries or minimal CAD, 73% had significant headache caused by sublingual GTN. In patients with obstructive CAD, only 23% had significant headache after GTN use (p < 0.001). There were no differences in patients’ sex and vascular risk factors concerning the frequency of headache in patients with or without obstructive CAD.

Conclusions: GTN causes significantly more frequent headache episodes in patients with normal coronary arteries or minimal CAD than in patients with obstructive CAD. This unique finding may provide clinicians with an additional tool for the differential diagnosis of patients with chest pain syndrome.

Keywords: coronary artery disease; glyceryl trinitrate; headache; nitroglycerine


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

eLetters:

Read all eLetters

Patients who complain of headaches afler sublingual nitroglycerin usually have no coronary disease
Tsung O. Cheng
Online, 9 Sep 2005 [Full text]
Glyceryl trinitrate, headache and coronary artery disease: mechanistic and therapeutic uncertainties
Vinod K Gupta
Online, 2 Nov 2005 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.